Louise Morais Dornelas-Figueira

Dr. Louise Morais Dornelas-Figueira

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2015 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
RCRicardo Castro
Ricardo Castro
TSTrícia Murielly Pereira Andrade de Souza
Trícia Murielly Pereira Andrade de Souza
LDLouise Morais Dornelas-Figueira
Louise Morais Dornelas-Figueira
GFGabriela Lacet Silva Ferreira
Gabriela Lacet Silva Ferreira
ECEdja Maria Melo de Brito Costa
Edja Maria Melo de Brito Costa
ACAlessandro Leite Cavalcanti
Alessandro Leite Cavalcanti
Limitations of antifungal agents used in the treatment of oral candidiasis, as the development of resistant strains, are known by the scientific community. In this context, the aim of this study was to evaluate the antifungal activity of thymol against Candida albicans, Candida tropicalis and Candida krusei strains and to determine its mode of action and synergistic effect when combined with the synthetic antifungal nystatin. The minimum inhibitory concentration (MIC) was determined using a microdilution technique, and the minimum fungicidal concentration (MFC) was determined via subculture sowing. The mode of action of thymol was established by verifying fungal growth in the presence of sorbitol or ergosterol. The fractional inhibitory concentration index (FIC) was determined using the checkerboard method. Thymol presented an antifungal effect, with MICs of 39 μg/mL for C. albicans and C. krusei and 78 μg/mL for C. tropicalis. The results of the antifungal test remained unchanged in the presence of sorbitol; however, the MIC value of thymol against C. albicans increased eight times (from 39.0 to 312.5 μg/mL) in presence of exogenous ergosterol. The combination of thymol and nystatin reduced the MIC values of both products by 87.4 %, generating an FIC index of 0.25. Thymol was found to have a fungicidal effect on Candida species and a synergistic effect when combined with nystatin.

1 January 2020 in Brazilian Oral Research
Verified
Journal Article
Open access
PDF file
LMLoyse Martorano-Fernandes
Loyse Martorano-Fernandes
LDLouise Morais Dornelas-Figueira
Louise Morais Dornelas-Figueira
RMRaissa Micaella Marcello-Machado
Raissa Micaella Marcello-Machado
RSRaíra de Brito Silva
Raíra de Brito Silva
MMMarcela Baraúna Magno
Marcela Baraúna Magno
ACAltair Antoninha Del Bel Cury
Altair Antoninha Del Bel Cury
Here, the prevalence of oral candidiasis and denture stomatitis among diabetic patients compared to healthy ones was summarized through a systematic review with meta-analysis. Medline, Scopus, Web of Science, Lilacs, Cochrane Library, Embase, and the grey literature were searched without restriction, until May 2020. Eligibility criteria were established, data were extracted, and quality assessment was conducted by two trained examiners. Qualitative synthesis was based on the recommendations of Fowkes and Fulton. Two meta-analyses were performed on studies investigating patients with: a) oral candidiasis and b) denture stomatitis. Out of 6034 screened studies, seven were eligible for qualitative and quantitative synthesis; of these, three evaluated oral candidiasis and four evaluated denture stomatitis. Qualitative synthesis showed that the main methodological problems of the studies included sample size, source of controls, matching, and randomization. Diabetic patients had a similar chance of developing oral candidiasis to non-diabetic patients (OR1.40 [0.96; 2.04], p = 0.08, I2 = 94%). However, diabetic patients had a higher chance to present denture stomatitis compared to non-diabetic patients (OR 1.92 [1.42, 2.59] p < 0.0001, I2 = 0%). Therefore, diabetic patients have a higher chance of developing denture stomatitis compared to non-diabetic patients. However, for all analyses, the certainty of the evidence was considered to be very low.

1 February 2018 in Brazilian Journal of Biology
Verified
Journal Article
Open access
PDF file
GFG. L. S. Ferreira
G. L. S. Ferreira
LBL. M. D. Bezerra
L. M. D. Bezerra
IRI. L. A. Ribeiro
I. L. A. Ribeiro
LDLouise Morais Dornelas-Figueira
Louise Morais Dornelas-Figueira
RCRicardo Castro
Ricardo Castro
This study aimed to evaluate the in vitro antibacterial activity of the phytochemicals thymol, linalool, and citronellol against Streptococcus mutans, Streptococcus salivarius and Streptococcus oralis. Disk diffusion screening on solid medium and measurement of the diameter of the bacterial growth inhibition halos was the technique utilized. The Minimum Inhibitory Concentration (MIC) of the substances was determined using serial substance dilutions and microdilution technique in Brain Heart Infusion culture medium. After incubation for 24 hours in an oven at 37 °C, plate reading was completed and confirmed by visual method using 2,3,5 triphenyl tetrazolium chloride dye. The Minimum Bactericidal Concentration (MBC) was determined from MIC subcultures. Assays were performed in triplicate, and chlorhexidine was used as a positive control. The diameters in mm of the growth inhibition halos ranged between 7.3 and 10.7 for S. mutans, 7.3 and 10.0 for S. oralis, and 8.2 and 9.8 for S. salivarius. The MIC and MBC values obtained converged, ranging from maximum values in the presence of Linalool (1,250.0 mg/mL, 2,500.0 mg/mL and 2,500.0 mg/mL, respectively, for S. mutans, S. oralis, and S. salivarius); and minimum values with Thymol (312.5 μg/ml, 156.2 μg/mL and 156.2 μg/ml, respectively for S. mutans, S. oralis, and S. salivarius). All the tested phytochemicals displayed antibacterial activity, thus representing substances with potential applications in preventing tooth decay.

11 September 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
LDLouise Morais Dornelas-Figueira
Louise Morais Dornelas-Figueira
AFAntônio Pedro Ricomini Filho
Antônio Pedro Ricomini Filho
RJRoger Junges
Roger Junges
HÅHeidi Aarø Åmdal
Heidi Aarø Åmdal
ACAltair Antoninha Del Bel Cury
Altair Antoninha Del Bel Cury
FPFernanda Cristina Petersen
Fernanda Cristina Petersen
Antifungal agents are widely used to specifically eliminate infections by fungal pathogens. However, the specificity of antifungal agents has been challenged by a few studies demonstrating antibacterial inhibitory effects against Mycobacteria and Streptomyces species. Here, we evaluated for the first time the potential effect of fluconazole, the most clinically used antifungal agent, on a human oral microbiota biofilm model. The results showed that biofilm viability on blood and mitis salivarius agar media was increased over time in the presence of fluconazole at clinically relevant concentrations, despite a reduction in biomass. Targeted PCR revealed a higher abundance of Veillonella atypica, Veillonella dispar, and Lactobacillus spp. in the fluconazole-treated samples compared to the control, while Fusobacterium nucleatum was reduced and Streptococcus spp were not significantly affected. Further, we tested the potential impact of fluconazole using single-species models. Our results, using Streptococcus mutans and Streptococcus mitis luciferase reporters, showed that S. mutans planktonic growth was not significantly affected by fluconazole, whereas for S. mitis, planktonic growth, but not biofilm viability, was inhibited at the highest concentration. Fluconazole’s effects on S. mitis biofilm biomass were concentration and time dependent. Exposure for 48 h to the highest concentration of fluconazole was associated with S. mitis biofilms with the most increased biomass. Potential growth inhibitory effects were further tested using four non-streptococcal species. Among these, the planktonic growth of both Escherichia coli and Granulicatella adiacens was inhibited by fluconazole. The data indicate bacterial responses to fluconazole that extend to a broader range of bacterial species than previously anticipated from the literature, with the potential to disturb biofilm communities.

6 October 2019 in Journal of Oral Rehabilitation
Verified
Journal Article
Closed access
PDF file
CRCynthia Valeria Silva Gomes Ribeiro
Cynthia Valeria Silva Gomes Ribeiro
DRDjalma Ribeiro‐Sobrinho
Djalma Ribeiro‐Sobrinho
VMVictor Muñoz
Victor Muñoz
LDLouise Morais Dornelas-Figueira
Louise Morais Dornelas-Figueira
ACAltair Antoninha Del Bel Cury
Altair Antoninha Del Bel Cury

31 May 2013 in Revista Brasileira de Ciências da Saúde
Verified
Journal Article
Open access
PDF file
LDLouise Morais Dornelas-Figueira
Louise Morais Dornelas-Figueira
GFGls Ferreira
Gls Ferreira
ISIcg Silva
Icg Silva
RCRd Castro
Rd Castro
ATIVIDADE ANTIBACTERIANA IN VITRO DE FITOCONSTITUINTES SOBRE MICORGANISMOS DO BIOFILME DENTÁRIO